Abstract
Colonoscopy with polypectomy is the means by which the incidence of colon cancer may be reduced; however, polypectomy is not without risk. Physicians must carefully weigh the risks and benefits of colonoscopy, particularly when patients are given prescriptions for antiplatelet agents and anticoagulants. This article discusses the risks of colonoscopy and polypectomy and reviews the most recent data for managing antiplatelet agents and anticoagulants in the periendoscopic period.
Original language | English (US) |
---|---|
Pages (from-to) | 125-135 |
Number of pages | 11 |
Journal | Medical Clinics of North America |
Volume | 103 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2019 |
Keywords
- Anticoagulants
- Antiplatelet agents
- Colonoscopy
- Gastrointestinal hemorrhage
- Polypectomy
- Risks
ASJC Scopus subject areas
- Medicine(all)